Skip to main content
PMC home page
Saudi Journal of Biological Sciences logoLink to Saudi Journal of Biological Sciences
. 2016 Jan 25;24(4):950–955. doi: 10.1016/j.sjbs.2016.01.033

Antibacterial activities of the methanol extracts of Albizia adianthifolia, Alchornea laxiflora, Laportea ovalifolia and three other Cameroonian plants against multi-drug resistant Gram-negative bacteria

Cedric F Tchinda 1, Igor K Voukeng 1, Veronique P Beng 1, Victor Kuete 1,⁎
PMCID: PMC5415118  PMID: 28490970

Abstract

In the last 10 years, resistance in Gram-negative bacteria has been increasing. The present study was designed to evaluate the in vitro antibacterial activities of the methanol extracts of six Cameroonian medicinal plants Albizia adianthifolia, Alchornea laxiflora, Boerhavia diffusa, Combretum hispidum, Laportea ovalifolia and Scoparia dulcis against a panel of 15 multidrug resistant Gram-negative bacterial strains. The broth microdilution was used to determine the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of the extracts. The preliminary phytochemical screening of the extracts was conducted according to the reference qualitative phytochemical methods. Results showed that all extracts contained compounds belonging to the classes of polyphenols and triterpenes, other classes of chemicals being selectively distributed. The best antibacterial activities were recorded with bark and root extracts of A. adianthifolia as well as with L. ovalifolia extract, with MIC values ranging from 64 to 1024 μg/mL on 93.3% of the fifteen tested bacteria. The lowest MIC value of 64 μg/mL was recorded with A. laxiflora bark extract against Enterobacter aerogenes EA289.

Finally, the results of this study provide evidence of the antibacterial activity of the tested plants and suggest their possible use in the control of multidrug resistant phenotypes.

Keywords: Albizia adianthifolia, Antibacterial activity, Gram-negative bacteria, Laportea ovalifolia, Medicinal plants, Multidrug resistance

1. Introduction

Bacterial infections are of particular concern globally mainly due to the development of antibiotic resistance. In the last 10 years, resistance in Gram-negative bacteria has been increasing (Pallett and Hand, 2010). Gram-negative bacteria rapidly develop drug resistance, especially in the presence of antibiotic selection pressure (Boucher et al., 2009, Peleg and Hooper, 2010). In Gram-negative bacteria, efflux pumps belonging to the resistance-nodulation-cell division (RND) family of tripartite efflux pumps are largely involved in multidrug resistance (Van Bambeke et al., 2006). The spread of multidrug resistant (MDR) bacteria propels the search of novel antibacterials to combat resistant phenotypes. Botanicals constitute a good source of anti-infective compounds, in regards to the variety and diversity of their chemical structures (Cowan, 1999, Ndhlala et al., 2013, Ngameni et al., 2013). According to the World Health Organization (WHO) report, approximately 80% of the world population rely on plants or derived products for their treatment (WHO, 1993). In the past, many African plants demonstrated good antibacterial activity against Gram-negative MDR bacteria. Among the best documented plants are Olax subscorpioïdea (Fankam et al., 2011), Cucurbita pepo (Noumedem et al., 2013b), Piper nigrum (Noumedem et al., 2013a), Beilschmiedia obscura (Fankam et al., 2014), Capsicum frutescens (Touani et al., 2014), Allanblackia gabonensis, Combretum molle, Gladiolus quartinianus (Fankam et al., 2015) and Fagara tessmannii (Tankeo et al., 2015). In our continuos search of antibacterials from botanical source, we designed the present work to investigate in vitro, the antibacterial activity of the methanol extracts of six Cameroonian medicinal plants: Albizia adianthifolia (Schum.) (Fabaceae), Alchornea laxiflora (Benth.) Pax & K Hoffm. (Euphorbiaceae), Boerhavia diffusa Lin (Nyctaginaceae), Combretum hispidum Laws (Combretaceae), Laportea ovalifolia (Schum.) Chew (Urticaceae) and Scoparia dulcis Linn. (Scrophulariaceae) against MDR Gram-negative bacteria.

2. Materials and methods

2.1. Plant material and extraction

Different parts of the tested plants were collected in various parts of Cameroon in January 2014. These included the bark and roots of A. adianthifolia, the leaves and bark of A. laxiflora and C. hispidum, and the whole plant of B. diffusa, L. ovalifolia and S. dulcis. The plants were identified at the National herbarium (Yaounde, Cameroon) where voucher specimens were deposited under the reference numbers (Table 1). Each plant sample was air dried in laboratory temperature (22 ± 2 °C) and then powdered. The obtained powder (200 g) was extracted with methanol (MeOH; 1 L) for 48 h at room temperature. The extract was then concentrated under reduced pressure at about 40 °C to give residue that constituted the crude extract. All extracts were then kept at 4 °C until further use.

Table 1.

Information on the studied plants.

Species (family); voucher Number⁎ Traditional uses Parts used traditionally Bioactive or potentially bioactive components Bioactivity of crude extract
Albizia adianthifolia (Schum.) (Fabaceae); 24729/SRF/Cam Treatment skin diseases, bronchitis, inflamed eyes, tapeworm, headaches and sinusitis (Van-Wyk and Gerick, 2000, Watt and Breyer-Brandwyk, 1962) Leaves, bark and roots Adianthifoliosides A, B, D (Haddad et al., 2004, Haddad et al., 2003), lupeol and aurantiamide acetate (Tamokou Jde et al., 2012), prosapogenins (Haddad et al., 2002) Ethylaceate fraction extracts: antimicrobial on Ec, Ef, Pa, Pm, Kp, Sa, Sf, St, Ca, Ct, Ck, Cg, Cl, Cn (Tamokou Jde et al., 2012); Aqueous extract: antioxidant (Beppe et al., 2014, Tamokou Jde et al., 2012)
Alchornea laxiflora (Benth.) Pax & K Hoffm. (Euphorbiaceae); 9661/SRF/Cam Treatment inflammatory and infectious diseases, poliomyelitis and measles. (Ogundipe et al., 2001, Oladunmoye and Kehinde, 2011) Leaves, bark and roots Quercetin-7,4′-disulphate, quercetin, quercetin-3′,4′-disulphate, quercetin-3,4′-diacetate, rutin and quercetrin (Ogundipe et al., 2001) Methanol fraction of leave extracts: antimicrobial on Ba, Bc, Ec, Kp, Pa, Pf, Sa, Ag, Af, As, Ca, Cp (Akinpelu et al., 2015); Crude extract: antioxidant (Farombi et al., 2003)
Boerhavia diffusa Lin (Nyctaginaceae); 15247/SRF/Cam Treatment of diabetes, asthma, Bronchial infection (Kouakou et al., 2009) Whole plant Boeravinones G, H (Ahmed-Belkacem et al., 2007) Crude extract of leaves: Antioxidant and hepatoprotective properties (Olaleye et al., 2010), antimicrobial activity: Pa, Ec, St, Sf (Wagh and Vidhale, 2010)
Combretum hispidum Laws (Combretaceae); 48289/HNC Treatment of stomach aches, diarrhea, gastro-intestinal disorders, liver complaints, skin infections, urinary tract infections (Adjanohoun et al., 1996, Burkill, 1985, Jiofack et al., 2009) Leaves, roots Not reported Crude extract of bark: anti-hepatotoxic, anti-inflammatory, antiparasitic, mollucidal effect (Schmelzer and Gurib-Fakim, 2013)
Laportea ovalifolia (Schum.) Chew (Urticaceae) 44306/HNC Treatment of headache, internal ulcers, diabetes, bronchitis and filariasi (Focho et al., 2009, Momo et al., 2006) Leaves and roots Laportoside A and Laportomide A (Tazoo et al., 2007) Crude extract of leaves: antidiabetic and hypolipidemic effects (Momo et al., 2006)
Scoparia dulcis Linn. (Scrophulariaceae) 53478/HNC Treatment of anemia, burns, headaches, bronchitis, gastric disorders, hemorrhoids, insect bites, skin wounds, hypertension. (Freire et al., 1996) Whole plant Scoparinol (Ahmed et al., 2001); scoparic acid, scopadulcic acid, scopadulciol and scopadulin (Zulfiker et al., 2011) Crude extracts: anti-diabetic, anti-inflammatory properties and antioxidant capacity in vivo (Adaikpoh et al., 2007, Freire et al., 1996)
Open in a new tab
⁎

(HNC): Cameroon National Herbarium; (SRF/Cam): Société des Réserves Forestières du Cameroun; As: Aspergillus niger; Ag: Aspergillus glaucus; Af: Aspergillus flavus; Ba: Bacillus anthracis; Bc: Bacillus cereus; Ca: Candida albicans; Cg: Candida glabrata; CK: Candida krusei; Cl: Candida lusitaniae; Cn: Cryptococcus neoformans; Cp: Candida pseudotropicalis; Ct: Candida tropicalis; Ec: Escherichia coli; Ef: Enterococcus faecalis; Kp: Klebsiella pneumoniae; Pa: Pseudomonas aeruginosa; Pf: Pseudomonas fluorescens; Pm: Proteus mirabilis; Sa: Staphylococcus aureus; Sf: Shigella flexneri; St: Salmonella typhi.

2.2. Preliminary phytochemical screening

The major phytochemical classes such as alkaloids, triterpenes, flavonoids, anthraquinones, polyphenols, sterols, coumarins, saponins and tannins (Table 2) were investigated according to the common described phytochemical methods (Harbone, 1973, Ngameni et al., 2013, Poumale et al., 2013, Wansi et al., 2013).

Table 2.

Qualitative phytochemical composition of the plant extracts.

Classes Studies plants and composition
Albizia adianthifolia
 Alchornea laxiflora
 Boerhavia diffusa Combretum hispidum
 Laportea ovalifolia Scoparia dulcis
B R L B W L B W W
Alkaloids + + + + + + + − +
Polyphenols + + + + + + + + +
Flavonoids + + + + + + + − +
Anthraquinones + + − − + + + − −
Coumarins + + − − − − − + −
Tannins + − + − + + + + +
Triterpenes + + + + + + + + +
Sterols + + + + − + + − +
Saponins + + + − + + + + +
Open in a new tab

(−): Absent; (+): Present; the tested extracts were obtained from (L: Leaves; B: bark; R: roots; W: whole plant).

2.3. Antimicrobial assays

2.3.1. Chemicals for antimicrobial assay

Chloramphenicol (CHL) (Sigma–Aldrich, St. Quentin Fallavier, France) was used as reference antibiotics (RA). p-Iodonitrotetrazolium chloride (INT) was used as the microbial growth indicator (Eloff, 1998, Mativandlela et al., 2006).

2.3.2. Microbial strains and culture media

The studied microorganisms included sensitive and resistant strains of Pseudomonas aeruginosa, Klebsiella pneumoniae, Enterobacter aerogenes, Escherichia coli and Providencia stuartii obtained from the American Type Culture Collection (ATCC) as well as clinical strains. Their bacterial features were previously reported (Lacmata et al., 2012, Seukep et al., 2013, Touani et al., 2014). Nutrient agar (Sigma–Aldrich) was used for the activation of the tested Gram-negative bacteria while the Mueller Hinton Broth (Sigma–Aldrich) was used for antibacterial assays (Kuete et al., 2011b).

2.3.3. INT colorimetric assay for minimal inhibitory concentration and minimal bactericidal concentration determinations

The MIC determination on the tested bacteria were conducted using rapid INT colorimetric assay according to described methods (Eloff, 1998) with some modifications (Kuete et al., 2008b, Kuete et al., 2009). The test samples and RA were first of all dissolved in DMSO/Mueller Hinton Broth (MHB) broth. The final concentration of DMSO was lower than 2.5% and does not affect the microbial growth (Kuete et al., 2007, Kuete et al., 2008a). The solution obtained was then added to MHB, and serially diluted two fold (in a 96-wells microplate). One hundred microliters (100 μL) of inoculum 1.5 × 106 CFU/mL prepared in appropriate broth were then added (Kuete et al., 2008b, Kuete et al., 2009). The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a plate shaker and incubated at 37 °C for 18 h. The assay was repeated thrice. Wells containing adequate broth, 100 μL of inoculum and DMSO to a final concentration of 2.5% served as the negative control. The MIC of samples was detected after 18 h incubation at 37 °C, following the addition (40 μL) of 0.2 mg/mL of INT and incubation at 37 °C for 30 min. Viable bacteria reduced the yellow dye to pink. MIC was defined as the sample concentration that prevented the color change of the medium thus exhibited complete inhibition of microbial growth (Eloff, 1998). The MBC was determined by adding 50 μL aliquots of the preparations, which did not show any growth after incubation during MIC assays, to 150 μL of adequate broth. These preparations were incubated at 37 °C for 48 h. The MBC was regarded as the lowest concentration of extract, which did not produce a color change after the addition of INT as mentioned above (Kuete et al., 2008b, Kuete et al., 2009).

3. Results and discussion

The results of Table 2 reporting the qualitative phytochemical analysis indicated that all the tested plant extracts contained polyphenols and triterpenes. Except the extract from L. ovalifolia, all other crude extracts contained alkaloids, other secondary metabolite classes being selectively distributed (Table 2). The antibacterial data compiled in Table 3 showed that all the tested extracts displayed selective antibacterial activities. The best activity was recorded with bark and root extracts of A. adianthifolia as well as with L. ovalifolia extract, with MIC values ranging from 64 to 1024 μg/mL against 14/15 (93.3%) tested bacteria. The antibacterial activity with MIC values ranged from 64 to 1024 μg/mL for leaves [12/15 (80%) of the tested bacteria] and bark [10/15 (66.7%)] of A. laxiflora, [10/15 (66.7%)] for B. diffusa, for leaves [8/15 (53.3%)] and bark [3/15 (20%)] of C. hispidum and [6/15 (40%)] for S. dulcis extracts was obtained. The lowest MIC value (64 μg/mL) was recorded with A. laxiflora bark extract against E. aerogenes EA289. In almost all cases, the tested extract exerted bacteriostatic effects with a ratio MBC/MIC above 4.

Table 3.

MICs and MBCs in μg/mL of methanol extracts from the studied plants and chloramphenicol.

Bacterial strains Tested samples, MIC and MBC (in bracket) values (μg/mL)
Albizia adianthifolia
 Alchornea laxiflora
 Boerhavia diffusa Combretum hispidum
 Laportea ovalifolia Scoparia dulcis CHL
B R L B W L B W W
Escherichia coli
ATCC8739 128 (–) 128 (1024) 256 (–) 1024 (–) 1024 (–) - – 512 (–) – 2 (64)
ATCC10536 512 (–) 256 (–) 128 (–) 512 (–) 1024 (–) – – 1024 (–) – 2 (32)
AG100ATet 256 (–) 256 (–) – – 1024 (–) – – 512 (–) 1024 (–) 32 (256)
AG102 1024 (–) 1024 (–) 256 (–) 512 (–) 512 (–) 1024 (–) 512 (–) 512 (–) 1024 (–) 32 (256)



Enterobacter aerogenes
ATCC13048 256 (–) 128 (1024) 512 (–) 512 (–) 1024 (–) – – 256 (–) – 16 (128)
CM64 256 (–) 128 (512) 512 (–) 512 (–) 1024 (–) 512 (–) 512 (–) 512 (–) 1024 (–) 256 (–)
EA 27 256 (–) 256 (–) 128 (1024) – 1024 (–) 512 (–) – 512 (–) – 32 (256)
EA 289 128 (–) 128 (–) 128 (1024) 64 (1024) 512 (–) 256 (–) 1024 (–) 256 (–) 256 (–) 32 (256)



Klebsiella pneumoniae
ATCC11296 128 (–) 128 (–) 256 (–) 256 (–) – – – 1024 (–) – 32 (256)
KP55 256 (–) 256 (–) 512 (–) 512 (–) – 1024 (–) – 512 (–) – 64 (256)
KP63 128 (–) 128 (–) 512 (–) – 1024 (–) – – 256 (–) – 32 (256)



Providencia stuartii
ATCC29916 512 (–) 512 (–) – 512 (–) – 1024 (–) – 256 (–) 1024 (–) 64 (256)
NEA 16 512 (–) 1024 (–) 128 (–) – 512 (–) 512 (–) – 128 (–) 512 (–) 64 (256)



Pseudomonas aeruginosa
PA01 256 (–) 128 (–) 512 (–) 512 (–) – 512 (–) – 256 (–) – 64 (–)
PA124 – – – – – – – – – 256 (–)
Open in a new tab

–: >1024 (MIC) or not determined; the tested extracts were obtained from (L: Leaves; B: bark; R: roots; W: whole plant); CHL: chloramphenicol.

Several molecules belonging to the detected classes of secondary metabolites were found active on pathogenic microorganisms (Awouafack et al., 2013, Cowan, 1999, Ndhlala et al., 2013, Tsopmo et al., 2013). The presence of such metabolites in the studied plant extracts can provide a preliminary explanation on their antibacterial activities. Differences were observed in the antibacterial activities of the extracts. These could be due to the differences in their chemical composition as well as in the mechanism of action of their bioactive constituents (Cowan, 1999). According to Kuete, 2010, Kuete and Efferth, 2010, the antibacterial activity of a plant extract is considered significant when MIC values are below 100 μg/mL, moderate when 100 ⩽ MIC ⩽ 625 μg/mL and weak when MIC > 625 μg/mL. Consequently, the activity (MIC of 64 μg/mL) observed with A. laxiflora bark extract against E. aerogenes EA289 can be considered important. Moderate antibacterial activities (100 ⩽ MIC ⩽ 625 μg/mL) were obtained with the majority of the extracts. However, the obtained MIC values are very important when considering the medicinal importance of the tested MDR bacteria (Chevalier et al., 2000, Kuete et al., 2010, Kuete et al., 2011a, Mallea et al., 1998, Mallea et al., 2003, Pradel and Pages, 2002, Tran et al., 2010). The antibacterial activities of A. adianthifolia, A. laxiflora and B. diffusa was reported on many sensitive species (Akinpelu et al., 2015, Tamokou Jde et al., 2012, Wagh and Vidhale, 2010). The present work therefore provides additional data on their ability to combat MDR phenotypes.

4. Conclusion

The results of the present investigation suggest that the extracts of the studied plants can be used as potential leads to discover new drugs to control some bacterial infections, especially those involving MDR bacterial species.

Authors’ contributions

CTF and IKV carried out the study; VK and VPB supervised the work; VK designed the experiments, wrote the manuscript, supervised the work and provided the bacterial strains; all authors read and approved the final manuscript.

Acknowledgements

Authors are thankful to the Cameroon National Herbarium for the identification of plants.

Footnotes

Peer review under responsibility of King Saud University.

References

  1. Adaikpoh M., Orhue N., Igbe I. The protective role of Scoparia dulcis on tissue antioxidant defense system of rats exposed to cadmium. Afr. J. Biotechnol. 2007;6:1192–1196. [Google Scholar]
  2. Adjanohoun J., Aboubakar N., Dramane K., Ebot M., Ekpere J., Enow-Orock E., Focho D., Gbile Z., Kamanyi A., Kamsu-Kom J., Keita A., Mbenkum T., Mbi C., Mbiele A., Mbome L., Mubiru N., Nancy W., Nkongmeneck B., Satabie B., Sofowora A., Tamze V., Wirmum C., editors. Traditional medicine and pharmacopoeia: contribution to ethnobotanical and floristic studies in Cameroon. OUA/STRC; Lagos: 1996. [Google Scholar]
  3. Ahmed M., Shikha H.A., Sadhu S.K., Rahman M.T., Datta B.K. Analgesic, diuretic, and anti-inflammatory principle from Scoparia dulcis. Pharmazie. 2001;56:657–660. [PubMed] [Google Scholar]
  4. Ahmed-Belkacem A., Macalou S., Borrelli F., Capasso R., Fattorusso E., Taglialatela-Scafati O., Di Pietro A. Nonprenylated rotenoids, a new class of potent breast cancer resistance protein inhibitors. J. Med. Chem. 2007;50:1933–1938. doi: 10.1021/jm061450q. [DOI] [PubMed] [Google Scholar]
  5. Akinpelu D.A., Abioye E.O., Aiyegoro O.A., Akinpelu O.F., Okoh A.I. Evaluation of antibacterial and antifungal properties of Alchornea laxiflora (Benth.) Pax. & Hoffman. Evid. Based Complement Altern. Med. 2015;2015:684839. doi: 10.1155/2015/684839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Awouafack M.D., Tane P., Kuete V., Eloff J.N. 2-Sesquiterpenes from the medicinal plants of Africa. In: Kuete V., editor. Medicinal Plant Research in Africa: Pharmacology and Chemistry. Elsevier; Oxford: 2013. pp. 33–103. [Google Scholar]
  7. Beppe G.J., Dongmo A.B., Foyet H.S., Tsabang N., Olteanu Z., Cioanca O., Hancianu M., Dimo T., Hritcu L. Memory-enhancing activities of the aqueous extract of Albizia adianthifolia leaves in the 6-hydroxydopamine-lesion rodent model of Parkinson’s disease. BMC Complement Altern. Med. 2014;14:142. doi: 10.1186/1472-6882-14-142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boucher H.W., Talbot G.H., Bradley J.S., Edwards J.E., Gilbert D., Rice L.B., Scheld M., Spellberg B., Bartlett J. Bad bugs, no drugs: no ESKAPE! an update from the infectious diseases society of America. Clin. Infect. Dis. 2009;48:1–12. doi: 10.1086/595011. [DOI] [PubMed] [Google Scholar]
  9. Burkill H. Royal Botanic Gardens; Kew, Edinburgh: 1985. The Useful Plants of West Tropical Africa. [Google Scholar]
  10. Chevalier J., Pages J.M., Eyraud A., Mallea M. Membrane permeability modifications are involved in antibiotic resistance in Klebsiella pneumoniae. Biochem. Biophys. Res. Commun. 2000;274:496–499. doi: 10.1006/bbrc.2000.3159. [DOI] [PubMed] [Google Scholar]
  11. Cowan M.M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999;12:564–582. doi: 10.1128/cmr.12.4.564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eloff J.N. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria. Planta Med. 1998;64:711–713. doi: 10.1055/s-2006-957563. [DOI] [PubMed] [Google Scholar]
  13. Fankam A.G., Kuete V., Voukeng I.K., Kuiate J.R., Pages J.M. Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes. BMC Complement. Altern. Med. 2011;11:104. doi: 10.1186/1472-6882-11-104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fankam A.G., Kuiate J.R., Kuete V. Antibacterial activities of Beilschmiedia obscura and six other Cameroonian medicinal plants against multi-drug resistant Gram-negative phenotypes. BMC Complement. Altern. Med. 2014;14:241. doi: 10.1186/1472-6882-14-241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fankam A.G., Kuiate J.R., Kuete V. Antibacterial and antibiotic resistance modifying activity of the extracts from Allanblackia gabonensis, Combretum molle and Gladiolus quartinianus against Gram-negative bacteria including multi-drug resistant phenotypes. BMC Complement. Altern. Med. 2015;15:206. doi: 10.1186/s12906-015-0726-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Farombi E.O., Ogundipe O.O., Samuel Uhunwangho E., Adeyanju M.A., Olarenwaju Moody J. Antioxidant properties of extracts from Alchornea laxiflora (Benth) Pax and Hoffman. Phytother. Res. 2003;17:713–716. doi: 10.1002/ptr.1050. [DOI] [PubMed] [Google Scholar]
  17. Focho D., WT N., Fonge B. Medicinal plants of aguambu – bamumbu in the Lebialem highlands, southwest province of Cameroon. Afr. J. Pharm. Pharmacol. 2009;3:1–13. [Google Scholar]
  18. Freire S.M., Torres L.M., Souccar C., Lapa A.J. Sympathomimetic effects of Scoparia dulcis L. and catecholamines isolated from plant extracts. J. Pharm. Pharmacol. 1996;48:624–628. doi: 10.1111/j.2042-7158.1996.tb05985.x. [DOI] [PubMed] [Google Scholar]
  19. Haddad M., Khan I.A., Lacaille-Dubois M.A. Two new prosapogenins from Albizia adianthifolia. Pharmazie. 2002;57:705–708. [PubMed] [Google Scholar]
  20. Haddad M., Miyamoto T., Laurens V., Lacaille-Dubois M.A. Two new biologically active triterpenoidal saponins acylated with salicylic acid from Albizia adianthifolia. J. Nat. Prod. 2003;66:372–377. doi: 10.1021/np020391q. [DOI] [PubMed] [Google Scholar]
  21. Haddad M., Laurens V., Lacaille-Dubois M.A. Induction of apoptosis in a leukemia cell line by triterpene saponins from Albizia adianthifolia. Bioorg. Med. Chem. 2004;12:4725–4734. doi: 10.1016/j.bmc.2004.06.025. [DOI] [PubMed] [Google Scholar]
  22. Harbone J., editor. Phytochemical methods: a guide to modern techniques of plant analysis. Chapman & Hall; London: 1973. [Google Scholar]
  23. Jiofack T., Ayissi I., Fokunang C., Guedje N., Kemeuze V. Ethnobotany and phytomedicine of the upper Nyong valley forest in Cameroon. Afr. J. Pharm. Pharmacol. 2009;3:144–150. [Google Scholar]
  24. Kouakou S., Nguessan I., Kablan B. Activité antioxydante et antiélastasique de trois plantes à usage antiasthmatique en médecine traditionnelle. J. Sci. Pharm. Biol. 2009;12:6–12. [Google Scholar]
  25. Kuete V. Potential of Cameroonian plants and derived products against microbial infections: a review. Planta Med. 2010;76:1479–1491. doi: 10.1055/s-0030-1250027. [DOI] [PubMed] [Google Scholar]
  26. Kuete V., Efferth T. Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol. 2010;1:123. doi: 10.3389/fphar.2010.00123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kuete V., Wabo G.F., Ngameni B., Mbaveng A.T., Metuno R., Etoa F.X., Ngadjui B.T., Beng V.P., Meyer J.J., Lall N. Antimicrobial activity of the methanolic extract, fractions and compounds from the stem bark of Irvingia gabonensis (Ixonanthaceae) J. Ethnopharmacol. 2007;114:54–60. doi: 10.1016/j.jep.2007.07.025. [DOI] [PubMed] [Google Scholar]
  28. Kuete V., Ngameni B., Simo C.C., Tankeu R.K., Ngadjui B.T., Meyer J.J., Lall N., Kuiate J.R. Antimicrobial activity of the crude extracts and compounds from Ficus chlamydocarpa and Ficus cordata (Moraceae) J. Ethnopharmacol. 2008;120:17–24. doi: 10.1016/j.jep.2008.07.026. [DOI] [PubMed] [Google Scholar]
  29. Kuete V., Wansi J.D., Mbaveng A.T., Kana Sop M.M., Tadjong A.T., Beng V.P., Etoa F.X., Wandji J., Meyer J.J.M., Lall N. Antimicrobial activity of the methanolic extract and compounds from Teclea afzelii (Rutaceae) S. Af. J. Bot. 2008;74:572–576. [Google Scholar]
  30. Kuete V., Nana F., Ngameni B., Mbaveng A.T., Keumedjio F., Ngadjui B.T. Antimicrobial activity of the crude extract, fractions and compounds from stem bark of Ficus ovata (Moraceae) J. Ethnopharmacol. 2009;124:556–561. doi: 10.1016/j.jep.2009.05.003. [DOI] [PubMed] [Google Scholar]
  31. Kuete V., Ngameni B., Tangmouo J.G., Bolla J.M., Alibert-Franco S., Ngadjui B.T., Pages J.M. Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone. Antimicrob. Agents Chemother. 2010;54:1749–1752. doi: 10.1128/AAC.01533-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kuete V., Alibert-Franco S., Eyong K.O., Ngameni B., Folefoc G.N., Nguemeving J.R., Tangmouo J.G., Fotso G.W., Komguem J., Ouahouo B.M., Bolla J.M., Chevalier J., Ngadjui B.T., Nkengfack A.E., Pages J.M. Antibacterial activity of some natural products against bacteria expressing a multidrug-resistant phenotype. Int. J. Antimicrob. Agents. 2011;37:156–161. doi: 10.1016/j.ijantimicag.2010.10.020. [DOI] [PubMed] [Google Scholar]
  33. Kuete V., Kamga J., Sandjo L.P., Ngameni B., Poumale H.M., Ambassa P., Ngadjui B.T. Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae) BMC Complement. Altern. Med. 2011;11:6. doi: 10.1186/1472-6882-11-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lacmata S.T., Kuete V., Dzoyem J.P., Tankeo S.B., Teke G.N., Kuiate J.R., Pages J.M. Antibacterial activities of selected Cameroonian plants and their synergistic effects with antibiotics against bacteria expressing MDR phenotypes. Evid. Based Complement. Alternat. Med. 2012;2012:623723. doi: 10.1155/2012/623723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mallea M., Chevalier J., Bornet C., Eyraud A., Davin-Regli A., Bollet C., Pages J.M. Porin alteration and active efflux: two in vivo drug resistance strategies used by Enterobacter aerogenes. Microbiology. 1998;144(Pt 11):3003–3009. doi: 10.1099/00221287-144-11-3003. [DOI] [PubMed] [Google Scholar]
  36. Mallea M., Mahamoud A., Chevalier J., Alibert-Franco S., Brouant P., Barbe J., Pages J.M. Alkylaminoquinolines inhibit the bacterial antibiotic efflux pump in multidrug-resistant clinical isolates. Biochem. J. 2003;376:801–805. doi: 10.1042/BJ20030963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Mativandlela S.P.N., Lall N., Meyer J.J.M. Antibacterial, antifungal and antitubercular activity of (the roots of) Pelargonium reniforme (CURT) and Pelargonium sidoides (DC) (Geraniaceae) root extracts. S. Afr. J. Bot. 2006;72:232–237. [Google Scholar]
  38. Momo C.E., Oben J.E., Tazoo D., Dongo E. Antidiabetic and hypolipidaemic effects of a methanol/methylene-chloride extract of Laportea ovalifolia (Urticaceae), measured in rats with alloxan-induced diabetes. Ann. Trop. Med. Parasitol. 2006;100:69–74. doi: 10.1179/136485906X78517. [DOI] [PubMed] [Google Scholar]
  39. Ndhlala A.R., Amoo S.O., Ncube B., Moyo M., Nair J.J., Van Staden J. 16-Antibacterial, antifungal, and antiviral activities of African medicinal plants. In: Kuete V., editor. Medicinal Plant Research in Africa: Pharmacology and Chemistry. Elsevier; Oxford: 2013. pp. 621–659. [Google Scholar]
  40. Ngameni B., Fotso G.W., Kamga J., Ambassa P., Abdou T., Fankam A.G., Voukeng I.K., Ngadjui B.T., Abegaz B.M., Kuete V. 9-Flavonoids and related compounds from the medicinal plants of Africa. In: Kuete V., editor. Medicinal Plant Research in Africa: Pharmacology and Chemistry. Elsevier; Oxford: 2013. pp. 301–350. [Google Scholar]
  41. Noumedem J.A., Mihasan M., Kuiate J.R., Stefan M., Cojocaru D., Dzoyem J.P., Kuete V. In vitro antibacterial and antibiotic-potentiation activities of four edible plants against multidrug-resistant gram-negative species. BMC Complement. Altern. Med. 2013;13:190. doi: 10.1186/1472-6882-13-190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Noumedem J.A., Mihasan M., Lacmata S.T., Stefan M., Kuiate J.R., Kuete V. Antibacterial activities of the methanol extracts of ten Cameroonian vegetables against Gram-negative multidrug-resistant bacteria. BMC Complement. Altern. Med. 2013;13:26. doi: 10.1186/1472-6882-13-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ogundipe O.O., Moody J.O., Houghton P.J., Odelola H.A. Bioactive chemical constituents from Alchornea laxiflora (benth) pax and hoffman. J. Ethnopharmacol. 2001;74:275–280. doi: 10.1016/s0378-8741(00)00352-4. [DOI] [PubMed] [Google Scholar]
  44. Oladunmoye M., Kehinde F. Ethnobotanical survey of medicinal plants used in treating viral infections among Yoruba tribe of South Western Nigeria. Afr. J. Microbiol. Res. 2011;5:2991–3004. [Google Scholar]
  45. Olaleye M.T., Akinmoladun A.C., Ogunboye A.A., Akindahunsi A.A. Antioxidant activity and hepatoprotective property of leaf extracts of Boerhaavia diffusa Linn against acetaminophen-induced liver damage in rats. Food Chem. Toxicol. 2010;48:2200–2205. doi: 10.1016/j.fct.2010.05.047. [DOI] [PubMed] [Google Scholar]
  46. Pallett A., Hand K. Complicated urinary tract infections: practical solutions for the treatment of multiresistant Gram-negative bacteria. J. Antimicrob. Chemother. 2010;65(Suppl. 3) doi: 10.1093/jac/dkq298. iii25-33. [DOI] [PubMed] [Google Scholar]
  47. Peleg A., Hooper D. Hospital-acquired infections due to Gram-negative bacteria. N. Engl. J. Med. 2010;362:1804–1813. doi: 10.1056/NEJMra0904124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Poumale H.M.P., Hamm R., Zang Y., Shiono Y., Kuete V. 8-Coumarins and related compounds from the medicinal plants of Africa. In: Kuete V., editor. Medicinal Plant Research in Africa: Pharmacology and Chemistry. Elsevier; Oxford: 2013. pp. 261–300. [Google Scholar]
  49. Pradel E., Pages J.M. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 2002;46:2640–2643. doi: 10.1128/AAC.46.8.2640-2643.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schmelzer G., Gurib-Fakim A. Vol. 11. PROTA Foundation-CTA; Wageningen, Netherlands: 2013. Plant Resources of Tropical Africa. (Medicinal Plants). [Google Scholar]
  51. Seukep J.A., Fankam A.G., Djeussi D.E., Voukeng I.K., Tankeo S.B., Noumdem J.A., Kuete A.H., Kuete V. Antibacterial activities of the methanol extracts of seven Cameroonian dietary plants against bacteria expressing MDR phenotypes. Springerplus. 2013;2:363. doi: 10.1186/2193-1801-2-363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Tamokou Jde D., Simo Mpetga D.J., Keilah Lunga P., Tene M., Tane P., Kuiate J.R. Antioxidant and antimicrobial activities of ethyl acetate extract, fractions and compounds from stem bark of Albizia adianthifolia (Mimosoideae) BMC Complement. Altern. Med. 2012;12:99. doi: 10.1186/1472-6882-12-99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tankeo S., Damen F., Awouafack M., Mpetga J., Tane P., Eloff J., Kuete V. Antibacterial activities of the methanol extracts, fractions and compounds from Fagara tessmannii. J. Ethnopharmacol. 2015;169:275–279. doi: 10.1016/j.jep.2015.04.041. [DOI] [PubMed] [Google Scholar]
  54. Tazoo D., Krohn K., Hussain H., Kouam S., Dongo E. Laportoside A and laportomide A: a new cerebroside and a new ceramide from leaves of Laportea ovalifolia. Z. Naturforsch. 2007;62b:1208–1212. [Google Scholar]
  55. Touani F.K., Seukep A.J., Djeussi D.E., Fankam A.G., Noumedem J.A., Kuete V. Antibiotic-potentiation activities of four Cameroonian dietary plants against multidrug-resistant Gram-negative bacteria expressing efflux pumps. BMC Complement. Altern. Med. 2014;14:258. doi: 10.1186/1472-6882-14-258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Tran Q.T., Mahendran K.R., Hajjar E., Ceccarelli M., Davin-Regli A., Winterhalter M., Weingart H., Pages J.M. Implication of porins in beta-lactam resistance of Providencia stuartii. J. Biol. Chem. 2010;285:32273–32281. doi: 10.1074/jbc.M110.143305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tsopmo A., Awah F.M., Kuete V. 12-Lignans and stilbenes from African medicinal plants. In: Kuete V., editor. Medicinal Plant Research in Africa. Elsevier; Oxford: 2013. pp. 435–478. [Google Scholar]
  58. Van Bambeke F., Pages J.M., Lee V.J. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat Antiinfect Drug Discov. 2006;1:157–175. doi: 10.2174/157489106777452692. [DOI] [PubMed] [Google Scholar]
  59. Van-Wyk B., Gerick N. Briza publications; Pretoria: 2000. People’s plants: a guide to useful plants of Southern Africa. [Google Scholar]
  60. Wagh S., Vidhale N. Antimicrobial efficacy of Boerhaavia diffusa against some human pathogenic bacteria and fungi Biosci Biotechnol Res. Asia. 2010;7:267–272. [Google Scholar]
  61. Wansi J.D., Devkota K.P., Tshikalange E., Kuete V. 14-Alkaloids from the medicinal plants of Africa. In: Kuete V., editor. Medicinal Plant Research in Africa: Pharmacology and Chemistry. Elsevier; Oxford: 2013. pp. 557–605. [Google Scholar]
  62. Watt J., Breyer-Brandwyk M. Livingstone; London: 1962. The medicinal and poisonous plants of Southern and Easthern Africa. [Google Scholar]
  63. WHO, 1993. Summary of WHO guidelines for assessment of herbal medicines. Herbal Gram, vol. 28, pp. 13–14.
  64. Zulfiker A.H.M.D., Siddiqua A., Mahar L., Habib M.D.R., Uddin N., Hasan A., Rana S. In vitro antibacterial, antifungal and cytotoxicic activity of Scoporia dulcis L. Int. J. Pharm. Pharmacetut. Sci. 2011;3(Suppl. 2):188–203. [Google Scholar]

Articles from Saudi Journal of Biological Sciences are provided here courtesy of Elsevier

RESOURCES